医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Ornithine Laboratory: Longevity Superpower – Japan’s 70 Year-Olds Battling in 100m Race Captured in a Video Release

2012年11月06日 AM12:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)

View and Share Photo

Close Window


TOKYO

On Wednesday October 24, 2012, the Ornithine Laboratory has made a new video available to the public on its website for the ‘Japan Otsukare University, Faculty of Ornithine’ (literally University of Fatigue, Faculty of Ornithine – http://www.otsukare-univ.jp/). The site was established for the fictional university, with a goal of ‘eliminating fatigue in the world’.
This video depicts a showdown between Kageki Shimoda and Pe Hayashiya in a powerful, colorful 100-meter dash like never before seen. Shimoda is a holder of one of the most prestigious literary awards in Japan – the Naoki Prize. Hayashiya is a comic-chat artist, one of Japan’s historic traditional arts.

Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)

Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)

At the site (available in Japanese only) Shimoda plays the ‘tireless’ character; a school principal who combines radical fashion sense belying his age of 72 years, and intelligence. His challenger is 70 year-old Pe Hayashiya, a comedian known for his trademark pink outfits.

In this clip, you can watch the couple running the 100-meter race and navigating over jump-ropes. Take a moment and enjoy the video.

About the Ornithine Laboratory

The Ornithine Laboratory was established on October 28, 2009 as a non-profit scientific organization whose purpose is to educate and build global attention to ‘ornithine’. Ornithine is a type of free-amino-acid found in freshwater clams.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50462314&lang=en

CONTACT

Ornithine Laboratory
Natsumi Hayabuchi/Yoshiharu Asao,
+81-3-5770-6005 (available in Japanese only)
Public relations
office (in Integrate Co., Ltd)
press@ornithine.jp

同じカテゴリーの記事 

  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
  • Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
  • Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and Macau
  • BrainChip Earns Australian Patent for Improved Spiking Neural Network
  • Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies